Crossref
Alogliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
Clinical Medicine Reviews in Vascular Health · 2011
DOI: 10.4137/cmrvh.s3318 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Reviews in Vascular Health, 2011. Verfasst von Joshua J. Neumiller and Paul Milani.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Milani, J. J. N. A. P. (2011). Alogliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus. Clinical Medicine Reviews in Vascular Health. https://doi.org/10.4137/cmrvh.s3318
Vancouver
Milani JJNAP. Alogliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus. Clinical Medicine Reviews in Vascular Health. 2011. doi:10.4137/cmrvh.s3318
BibTeX
@article{Milani2011,
author = {Milani, Joshua J. Neumiller and Paul},
title = {Alogliptin: A DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus},
journal = {Clinical Medicine Reviews in Vascular Health},
year = {2011},
doi = {10.4137/cmrvh.s3318}
}
EUVIMED